Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9694002
Substituted benzamides and methods of use thereof
granted -
US 9693980
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 9694049
Methods for treating muscular dystrophy
granted -
US 9694079
Long-acting polymeric delivery systems
granted -
US 9695116
Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
granted -
US 9695475
Competitive modulation of microRNAs
granted -
US 9695195
5-HT3 receptor antagonists
granted -
US 9693962
Dry-coated tablet
granted -
US 9695243
Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
granted -
EP 3182958
ARIPIPRAZOL-PRODRUGZUSAMMENSETZUNG
granted -
US 9687551
Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
granted -
US 9687489
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
granted -
US 9688722
Substrates and inhibitors of prolyl oligopeptidase and methods of use
granted -
US 9687478
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 9687441
Compositions for use with a fascia tissue treatment device to reduce cellulite
granted -
US 9687542
Rift valley fever virus replicon particles and use thereof
granted -
US 9688764
Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies
granted -
US 9688616
Neprilysin inhibitors
granted -
US 9687481
Toxic aldehyde related diseases and treatment
granted -
US 9688987
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
granted -
US 9688748
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
granted -
US 9688739
T cell receptors and related materials and methods of use
granted -
US 9688726
Small molecule polypeptide for inhibiting inflammation
granted -
US 9688697
RNA polymerase I inhibitors and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.